Unraveling the Mysteries of Perineural Invasion in Benign and Malignant Conditions
- PMID: 37887547
- PMCID: PMC10605475
- DOI: 10.3390/curroncol30100647
Unraveling the Mysteries of Perineural Invasion in Benign and Malignant Conditions
Abstract
Perineural invasion (PNI) is defined as the dissemination of neoplastic cells within the perineural space. PNI can be a strong indicator of malignancy and is linked to poor prognosis and adverse outcomes in various malignant neoplasms; nevertheless, it can also be seen in benign pathologic conditions. In this review article, we discuss various signaling pathways and neurotrophic factors implicated in the development and progression of PNI. We also describe the methodology, benefits, and limitations of different in vitro, ex vivo, and in vivo models of PNI. The spectrum of presentation for PNI can range from diffuse spread within large nerves ("named" nerves) all the way through localized spread into unnamed microscopic nerves. Therefore, the clinical significance of PNI is related to its extent rather than its mere presence or absence. In this article, we discuss the guidelines for the identification and quantification of PNI in different malignant neoplasms based on the College of American Pathologists (CAP) and World Health Organization (WHO) recommendations. We also describe benign pathologic conditions and neoplasms demonstrating PNI and potential mimics of PNI. Finally, we explore avenues for the future development of targeted therapy options via modulation of signaling pathways involved in PNI.
Keywords: College of American Pathologists; TNM classification; World Health Organization; perineural invasion; staging.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10605475/bin/curroncol-30-00647-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10605475/bin/curroncol-30-00647-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10605475/bin/curroncol-30-00647-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10605475/bin/curroncol-30-00647-g004.gif)
Similar articles
-
Perineural invasion-associated biomarkers for tumor development.Biomed Pharmacother. 2022 Nov;155:113691. doi: 10.1016/j.biopha.2022.113691. Epub 2022 Sep 12. Biomed Pharmacother. 2022. PMID: 36095958 Review.
-
Molecular factors governing perineural invasion in malignancy.Surg Oncol. 2022 Jun;42:101770. doi: 10.1016/j.suronc.2022.101770. Epub 2022 Apr 14. Surg Oncol. 2022. PMID: 35490532 Review.
-
Clinical significance of perineural invasion in stages II and III colorectal cancer.Pathol Res Pract. 2015 Nov;211(11):839-44. doi: 10.1016/j.prp.2015.09.001. Epub 2015 Sep 4. Pathol Res Pract. 2015. PMID: 26429129
-
A novel classification system for perineural invasion in noncutaneous head and neck squamous cell carcinoma: histologic subcategories and patient outcomes.Am J Otolaryngol. 2012 Mar-Apr;33(2):212-5. doi: 10.1016/j.amjoto.2011.06.003. Epub 2011 Dec 15. Am J Otolaryngol. 2012. PMID: 22177613
-
Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens.Hum Pathol. 2001 Aug;32(8):828-33. doi: 10.1053/hupa.2001.26456. Hum Pathol. 2001. PMID: 11521227
References
-
- Casazza G.C., Monroe M.M. Chapter 36—Imaging Cutaneous Squamous Cell Carcinoma of the Head and Neck. In: Hamblin M.R., Avci P., Gupta G.K., editors. Imaging in Dermatology. Academic Press; Boston, MA, USA: 2016. pp. 491–504.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous